VITR — Vitrolife AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual income statement for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,681	3,234	3,512	3,609	3,440
Cost of Revenue
Gross Profit	1,046	1,780	1,978	2,139	2,003
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,245	2,602	7,101	2,826	8,275
Operating Profit	435	632	-3,589	783	-4,835
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	460	537	-3,712	674	-4,886
Provision for Income Taxes
Net Income After Taxes	344	394	-3,851	514	-5,013
Minority Interest
Net Income Before Extraordinary Items
Net Income	341	394	-3,850	513	-5,013
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	341	394	-3,851	513	-5,012
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.62	3.03	-7.67	3.84	-11
Dividends per Share